FDA Person
FDASean Y. Kassim
View detailed information about Sean Y. Kassim, including compliance records, violations, and related data.
Person Profile
FDA investigator.
Documents (16)
- WARNING LETTER · Binh Bui-Nguyen, MD · September 19, 2014
- WARNING LETTER · Gross, Howard M. M.D. · January 14, 2015
- WARNING LETTER · Alzohalli, Opada M.D. · August 14, 2013
- WARNING LETTER · Weiner, Gilbert R. · November 25, 2013
- WARNING LETTER · AB Science · September 26, 2014
- WARNING LETTER · Wise, John M. M.D. · March 28, 2014
- WARNING LETTER · Colorado Histo-Prep · May 10, 2013
- WARNING LETTER · Sewell, Michele M.D. · August 19, 2013
- WARNING LETTER · Fandino, Ana J. · May 22, 2013
- WARNING LETTER · Birhiray, Ruemu · September 5, 2013
- WARNING LETTER · Rogerio Lobo, M.D. · June 25, 2013
- WARNING LETTER · Aqua, Keith A. M.D. · March 17, 2014
- WARNING LETTER · CXL-USA, LLC · August 19, 2014
- WARNING LETTER · Taber, Louise A., MD · July 18, 2014
- WARNING LETTER · Michlin, Bernard A., MD · January 23, 2015
- WARNING LETTER · AMKS TIME RELEASE LAB, LLC · July 12, 2013
Person Information
Name
Sean Y. Kassim
Title
Deputy Office Director
Role
Regulatory Personnel
ID: 8ff9d375-c771-4b7b-b420-111408ffbe47
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.